Fractional exhaled nitric oxide and its correlation with bioptic results in chronic cough patients


Authors: J. Votruba 1;  P. Čáp 2
Authors‘ workplace: Nemocnice Na Homolce Praha, Centrum plicní endoskopie 1;  Nemocnice Na Homolce Praha, Centrum alergologie a klinické imunologie 2
Published in: Čas. Lék. čes. 2009; 148: 429-433
Category: Original Article

Overview

Background.
Chronic nonproductive cough in nonsmokers with negative thoracic X-ray and normal spirometry is frequently encountered problem in the out-patient departments of specialists both pneumologists and allergologists. A lot of those patients present with already ongoing treatment with inhaled steroids. This work attempted to find valid markers of inflammation in our group of patients.

Methods and results :
ICS naive nonsmokers with negative X-ray of the chest, ACE-inhibitors non-users with no signs of UACS have been examined by bronchoscopy and FENO. Combination of these two methods aimed to confirm or exclude presence of bronchial inflammation. Recommendation for treatment with ICS can be more valid based on positive results. Very small number of patients with eosinophilic type of bronchial inflammation on biopsy (3 from total no.48) was found. In the group of those 3 patients with possitive finding of eosinophilia in mucosa – regarding changes there were also high values of FENO whereas in all other „allergy negative“ patients the FENO values were low.

Conclusion:
There was low incidence of eosinophilic inflammation in our group of chronic cough patients. Bronchoscopy and FENO were in good agreement in ruling out or in confirmation of eosinophilic inflammation. FENO appears to be good discriminator for ICS treatment decision in our group of patiens.

Key words:
chronic cough patients, FENO, bronchoscopy.

Chronic nonproductive cough in nonsmokers with negative chest X-ray and normal spirometry is frequently encountered problem in the out-patient departments of specialists both pneumologists and allergologists (1,2)

Precise and early diagnostics is a mainstem of succesful treatment in this patient population. This is however usually an uneasy problem. Not always it is possible to carry on all sensible diagnostic procedures. Due to different algorithms the patient might be the subject of very intense diagnostic program including pH metry and bronchoscopy which might lead to the refusal or decrease of patient compliance. Further frequent fact which complicates the diagnostic process is the concurrence of several causes of chronic cough in one patient.(3)

Three most often seen causative states are – problems in the nasopharynx and dorsal ethmoidal sinuses (UACS)- formerly postnasal drip syndrome, gastroesophagal reflux and asthmatic equivalent or cough variant asthma.(1,4,5,28). It is vital to exclude the side effect of ACE inhibitor during medical history taking . This is not always done in the office of primary physician.(6). We can also conclude that the patient has got chronic bronchitis if there is an expectoration of the phlegm 3 months in row for 2 following years. Detailed review of the possible causes of chronic cough (the cough lasting more than 8 weeks) is out of the scope of this article.

Many patients come into the offices of specialists with polypragmatic treatment or already on the medication by inhaled steroids. Such a medication is not always sufficiently reasonable. This treatment approach is often the results of oversimplifying of the treatment accompanied by the common knowledge of minimal or zero risk resulting from such inhalation treatment. We have raised the question in our work if there are some signs of bronchial inflammation on pathologic assessment of the mucosa in the subset of randomly presented patients. Second question was if evaluation of FENO will be equally reliable as bronchoscopy in the assessment of (eosinofilic) inflammation of the bronchial airways. We considered bronchoscopy as standard procedure in this setting. We gave priority to FENO from the spectrum of existing exhaled markers due to its standardization (ATS). We have started from the premise confirmed by several studies that FENO is being a good marker of eosinophilic bronchial inflammation in steroid naïve (but not steroid treated) patients (7). There are reports as well illustrating that values of FENO in asthmatic patients correlate well with the activity of the disease. (8). FENO also correlates well with the findings in bronchial biopsies (9,10)

The use of exhaled nitric oxide for the diagnostic purposes originated in Karolinska Institute (Sweden) introduced by two independent teams. Gustafson in 1991 was the first who described and determined NO in the exhaled breath ad secondly Alving in 1993 determined practical correlation between FENO elevation and asthma severity in children population.(11,12)

It is impossible to consider the diagnosis of asthma and FENO congruent. It is however well possible to parallel asthma with eosinophilic inflammation in nine from ten patients (90% of asthma cased are accompanied by eosinophilic inflammation of the airways).

Exhaled nitric oxide is currently standardized in the areas of both sampling and measurement (13). One parameter cannot however describe all the complexity of the inflammatory reaction and it is why we have to interpret it with the knowledge of its limited diagnostic value. It is why some authors choose the denomination – prototype of non-invasive marker (14). It is impossible to overestimate the representative value of the FENO for such highly variable and heterogenic disease as asthma undoubtedly is. Proves of the FENO measurement significance are evident (15). There are many original articles describing this problems in every possible way.(14,16,17,18,19,20,21,22,23).

Originally FDA has permitted FENO measurement for the monitoring of the disease and treatment effect evaluation. Recently however there are many information supporting its use for diagnostic purposes.(24,25,26,27).

Combination of bronchoscopy with FENO measurement is not usually able to set up a clear diagnosis but it can prove or negate the inflammation in the bronchial mucosa by two independent means. By such method it is possible to express clear position towards local corticosteroid treatment.

From the everyday praxis point of view the presence of eosinophilic inflammation in the mucosa occurring in the chronic cough patients with negative X-ray of the chest and spirometric values is crucial and important factor influencing the therapeutic choice. (12,28).

Set of patients, methods

The aim of the study was to verify the presence of the signs of inflammation in the set of our patients by two independent methods (combination of invasive- bronchoscopy and noninvasive- FENO) and by that mean obtain the information about the proportion of the patients which would profit from anti-inflammatory therapy with local corticosteroids. The evalulated parameter was also agreement /disagreement of the histological/FENO examinations in the diagnosis of allergic inflammation of the airways. We took bronchoscopic finding as a golden standard from which the specificity and sensitivity of the FENO measurements were derived. Our further aim was to confirm our presumption that the amount of randomly examined patients with chronic cough with the proof of bronchial eosinophilic inflammation will be very small. This would also suggest that the proportion of the patients that would be indicated for the treatment with ICS would be low.

Inclusion criteria:

Included patients had been suffering from non-productive cough for more than 8 weeks. They were non-smokers with negative x-ray of the chest and normal spirometric values, nonusers of ACEi and no clinical signs of UACS (upper airway cough syndrome)- headache, rhinorhoea, postnasal dripping, nasal obstruction, mucosal oedema, increased tonsils and visible phlegm in the pharynx. They were also free of GER symptoms- including heartburns , singultus, regurgitation, halitosis, acidity feeling in the mouths, chronic nausea. None of the probands have been treated by per oral or inhaled corticosteroids (ICS). Patients with pre-existing pulmonary or bronchial disorder have been excluded.

Permitted medications were: symptomatic treatment by antitussic medications, expectorants, and antihistamines. No other anti-inflammatory therapy (antileukotrienes or cromones) has been approved.

Patients have not been examined by ENT specialist or pH metry until the examination by bronchoscopy + FENO unless there has been strong clinical suspicion on such a problem. In such a case however they have been excluded from the study.

Overall 56 patients (34 female and 22 men mean age 42 years) came to the office of allergologist of pulmonary specialist NNH with chronic cough lasting from 8 weeks to 7 years. They all have been subjected to basic examination (history, physical examination, X-ray of the chest and spirometry) and all of them had been examined by FENO followed by bronchoscopy including mucosal biopsy for histological examination. For the FENO assessment the analyzer NIOX MINO® (Aerocrine, Sweden) has been used measuring exhaled nitric oxide online in real time based of electrochemical detection.

Macroscopic appearance of the mucosa has influenced the choice of the place of biopsy (we have used modern diagnostic method as narrow ban imaging and autofluorescent bronchoscopy) . Relevant sample from bronchoscopic examination sufficient for pathology evaluation was obtained in 48 patients. Other patients have been excluded from the study.

Histology evaluation of eosinophilic infiltration was based on the description of eosinophilic mucosal inflammation and enlargement of basal membrane.

Results

Histologic evaluation: there were 91 biopsies taken from the overall 56 patients. In 48 patients (72 biopsies) materials were sufficient for the histologic evaluation . All these patients have also undergone the examination by FENO. There have been no other parameters evaluated than eosinophilic infiltration and thickness of the basal membrane as a marker of remodelation (cutoff 8 um). Concourse of both findings has been taken as indicator of eosinophilic inflammation.

Graph 1. 
Graph 1 depictures the difference  of the refference set of steroid naive  asthmatic patients  with our set of patients with chronic cough
Asthma: overall 59 persons, 28 women, Ø age 41,3 years (asthma), asthma mild to moderate - persistent
Chronic cough: overall 48 persons,12 men, Ø age 45,2 years (cough)
Graph 1. Graph 1 depictures the difference of the refference set of steroid naive asthmatic patients with our set of patients with chronic cough Asthma: overall 59 persons, 28 women, Ø age 41,3 years (asthma), asthma mild to moderate - persistent Chronic cough: overall 48 persons,12 men, Ø age 45,2 years (cough)

A
A

B
Picture 1. 
A) Normal finding NO 19 ppb
B) Histology finding of eosinophilic infiltration with the enlargement of the basal membrane NO 72 ppb
B Picture 1. A) Normal finding NO 19 ppb B) Histology finding of eosinophilic infiltration with the enlargement of the basal membrane NO 72 ppb

Positive finding is such way has been found in tree patients (6,8%). In none of the samples there has been eosinophilic infiltration without enlargement of the basal membrane and vice versa. In our group of patients bronchoscopic biopsy hence has been considered as golden standard for diagnosis of eosinophilic inflammation towards which there have been calculations of sensitivity specificity PPV and NPV of FENO in the exhaled air. FENO: positive findings (cutoff 25 ppb) in 4 patients from 48 evaluated (8,3%).

Discussion

The dilemma of the chronic cough is a significant one. To our best knowledge no study has correlated histology finding from bronchial biopsies with FENO levels in the group of patients with chronic cough. It has been however proven (9) that the FENO levels correlates with mucosal eosinophilic inflammation in endobronchial biopsies.

Different chapter can also be so called postinfectious (postviral) cough which can be often therapeutically difficult. (29)

In the situation of negative histology finding in the patients with chronic nonproductive cough in the association with the signs of recent respiratory viral disease the inhalation of necrodomil sodium can sometimes show surprising therapeutic effect.(30). Positive effect of this treatment is probably connected with calming down of the exposed nerve endings in the mucosal surface.

Serological methods are rather unreliable for the diagnosis of Chlamydia and Mycoplasma disease. We only prove the antibodies not the agent itself and hence its interpretation might be quite difficult. There is also some degree of sensoric hyperreactivity after viral respiratory tract infections.

The utility of bronchoscopic examination in the diagnosis of chronic cough is without doubts in the presence of the chest X-ray pathology. Data from the literature varies significantly. Optical examination of the bronchial tree itself gives surprising alternative diagnosis in only about 4% of patients with chronic nonproductive irritative cough. Some authors advocate the use of bronchoscopy in this settings (31) some see its diagnostic contribution as minimal (32). No study to our knowledge has compared histological findings with the FENO values it the chronic cough patients yet. It has however proven (9) that value of FENO correlates well with mucosal eosinophilic inflammation in endobronchial biopsies.

We have also to consider possible difference of chronic nonproductive cough in adult and pediatric patients (33).

We are well aware that there can be also another type of inflammation than eosinophilic in asthma, especially neutrophilic. We have not found neutrophilic infiltration in any of our biopsy samples and there is also no place of inhalation corticosteroids in the treatment of neutrophil based asthma.

1. Evaluation of FENOs diagnostic yield for eosinophilic inflammation. Compared to bronchoscopic biopsies
Evaluation of FENOs diagnostic yield for eosinophilic inflammation. Compared to bronchoscopic biopsies

Conclusion:

Only very small number of nonsmoking patients coming to specialized office with chronic nonproductive cough and normal spirometric values have got eosinophilic infiltration of the mucosa with enlargement of the basal membrane from the bronchobiopsy (6,8%). Consequently the anticipation that such patients would profit from the chronic local steroid therapy does not seem to be correct. From this perspective the patient should me more often examined to exclude UACS and GER at the expense of ad hoc steroid treatment. Positive correlation of bronchobiopsy and FENO (cutoff 25 ppb) for the diagnosis of eosinophilic inflammation with the high suspicion of asthma is highly significant. FENO in our set of patients has got formally high predictive value for the diagnosis of eosinophilic asthma(PPV 75%, NPV 100%). We are however well aware that it is difficult to draw firm conclusions from such a small set of probands.

Abbr:

  • ATS American Thoracic Society
  • ACE inhibitors inhibitors of the angiotensin converting enzyme
  • FENO fractionated expired nitric oxide
  • GER gastroesophageal reflux
  • PNDS post nasal drip
  • PPV positive predictive value
  • UACS upper airway cough syndrom
  • NNH Nemocnice Na Homolce
  • NPV negative predictive value
  • IKS inhalation corticosteroids
  • ppb parts per billion
  • PPV positive predictive value
  • TP true positivity
  • FP false positivity
  • SD standard deviation
  • TN true negativity

Sources

1. Čáp P, Vondra V. Kašel. Praha: Galerie Vltavín 2000.

2. Spector SL. Chronic cough: the allergist perspective. Lung 2008; 186 (Suppl. 1): 41–47.

3. Chronic cough – diagnostic aspects. Laryngorhinootologie 2008; 87: 468–475.

4. Pratter MR. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 2006; 129 (Suppl. 1): 63S–71S.

5. Čáp P. Kašel. In: Pneumologie. Praha: Karolinum 2005; 40–47.

6. Fujimura M, Ohkura N, Abo M, Furusho S, Waseda Y, Ichikawa Y, Hara J. Exhaled nitric oxide levels in patients with atopic cough and cough variant asthma. Respirology 2008; 13: 359–364.

7. Sadanaga T, Yoshimura M, Sakamoto T, Sumida H, Ogawa H. Enalapril – induced cough is associated with non-severe heart failure. Int J Cardiol 2009; 135; 2, 275–276.

8. Piancentini GL, Bodini A, Costella S, et al. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999; 13: 1386–1390.

9. Sippel JM, Holden WE,Tilles SA, et al. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol 2000; 106: 645–650.

10. Payne DN, Adcock IM, Wilson NM, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma,after treatment with oral prednisolon. Am J Respir Crit Care Med 2001; 164: 1376–1381.

11. van der Toorn LM, Oberbeek SE, de Jongste JC, et al. Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164: 2107–2113.

12. Alving K, Weitzberg E, Lundberg J. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6: 1368–1370.

13. Chatkin JM, Ansarin K, Silkoff PE, et al. Exhaled nitric oxide as a nonivasive assessment of chronic cough. Am J Respir Crit Care Med 1999; 159: 1810–1813.

14. American Thoracic Society Official Statement. Recommendation for a standardized ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005; 8: 912–930.

15. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax 2006, 9: 817–827.

16. Čáp P. Význam měření oxidu dusnatého u nemocných astmatem. Čas Lék čes 2004;143: 381–384.

17. Henriksen AH, Lingaas-Holmen T, Sue-Chu M, Bjermer L. Combine use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey. Eur Respir J 2000; 15: 849–855.

18. Holz O, Buhl R, Hausen T, von Berg A, Weber M, Worth H, Magnussen H. Measuring Airway Inflammation in Clinical Practice – Application and Interpretation. Pneumologie 2007; 3: 194–201.

19. Gustafsson LE, Lerone, AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biopsys Res Commun 1991; 181: 852–857.

20. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53: 91–95.

21. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001; 164: 738–743.

22. Kharitonov SA, Yates DH, Robbins A, Logan-Sinclai R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133–135.

23. Lim S, Jatakanon A, Meah S, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000; 55: 184–188.

24. Olin AC, Rosengren A, Thelle DS, Lissner L, Bake B, Toren K. Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 2006; 5: 1319–1325.

25. Berkman N, Avital A, Breuer R, et al. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provokation tests.Thorax 2005; 60: 383–388.

26. Deykin A, Massaro AF, Drazen JM, et al. Exhaled nitric oxide as a diagnostic test for asthma. Am J Respir Crit Care Med 2003; 165: 1597–1601.

27. Dupont LJ, Demedts MG,Verleden GM. Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma. Chest 2003; 123: 751–756.

28. Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma. Comparisons between exhaled nitric oxide measurement and conventional tests.Am J Respir Crit Care Med 2004; 169: 473–478.

29. Hahn PY, Morgenthaler TI, Lim KG. Use of Exhaled Nitric Oxide in Predicting Response to Inhaled Corticosteroids for Chronic Cough. Mayo Clin Proc 2007; 82: 1350–1355.

Labels
Addictology Allergology and clinical immunology Anaesthesiology, Resuscitation and Inten Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric dermatology & STDs Paediatric gastroenterology Paediatric gynaecology Paediatric surgery Paediatric cardiology Paediatric nephrology Paediatric neurology Paediatric clinical oncology Paediatric ENT Paediatric pneumology Paediatric psychiatry Paediatric radiology Paediatric rheumatology Paediatric urologist Diabetology Endocrinology Pharmacy Clinical pharmacology Physiotherapist, university degree Gastroenterology and hepatology Medical genetics Geriatrics Gynaecology and obstetrics Haematology Hygiene and epidemiology Hyperbaric medicine Vascular surgery Chest surgery Plastic surgery Surgery Medical virology Intensive Care Medicine Cardiac surgery Cardiology Clinical speech therapy Clinical microbiology Nephrology Neonatology Neurosurgery Neurology Nuclear medicine Nutritive therapist Obesitology Ophthalmology Clinical oncology Orthodontics Orthopaedics ENT (Otorhinolaryngology) Anatomical pathology Paediatrics Pneumology and ftiseology Burns medicine Medical assessment General practitioner for children and adolescents Orthopaedic prosthetics Clinical psychology Radiodiagnostics Radiotherapy Rehabilitation Reproduction medicine Rheumatology Nurse Sexuology Forensic medical examiner Dental medicine Sports medicine Toxicology Traumatology Trauma surgery Urology Laboratory Home nurse Phoniatrics Pain management Health Care Medical student
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account